Error: Could not add to watchlist. X

Salix Pharmaceuticals Ltd

+ Watchlist
SLXP:US
Acquired
SLXP:US was acquired by VRX:CN
USD
Volume
0
52Wk Range
86.00 - 172.98
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.71
Market Cap (USD)
-
Shares Outstanding (m)
64.249
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

Profile
Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. The Company markets its products to gastroenterologists in the U.S. through its own specialty sales force.
ADDRESS
8510 Colonnade Center Drive
Raleigh, NC 27615
United States
PHONE
1-919-862-1000
  • Thomas W D'Alonzo "Tom"
    Chairman/Acting CEO
  • William P Forbes
    Pres:Medical Research & Dev
  • Rick D Scruggs
    Exec VP:Business Development
  • Timothy J Creech "Tim"
    Senior VP:Finance & Administrative
  • William C Bertrand
    Acting Chief Operating Officer
Show More